The role of (auto)-phosphorylation in the complex activation mechanism of LRRK2

被引:6
|
作者
Athanasopoulos, Panagiotis S. [1 ,2 ]
Heumann, Rolf [2 ]
Kortholt, Arjan [1 ]
机构
[1] Univ Groningen, Dept Cell Biochem, Nijenborgh 7, NL-9747 AG Groningen, Netherlands
[2] Ruhr Univ Bochum, Fac Chem & Biochem, Mol Neurobiochem, Univ Str 150, D-44780 Bochum, Germany
基金
欧盟地平线“2020”;
关键词
GTPase; kinase; neuronal degeneration; Parkinson's disease; phosphatases; DISEASE-ASSOCIATED MUTATIONS; SYNAPTIC VESICLE TRAFFICKING; PARKINSONS-DISEASE; KINASE-ACTIVITY; GTP-BINDING; PHOSPHORYLATION; PENETRANCE; PHENOTYPE; DISRUPTS;
D O I
10.1515/hsz-2017-0332
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in human leucine-rich-repeat kinase 2 (LRRK2) have been found to be the most frequent cause of late-onset Parkinson's Disease (PD). LRRK2 is a large protein with two enzymatic domains, a GTPase and a kinase domain. A cluster of (auto)-phosphorylation sites within the N-terminus of LRRK2 have been shown to be crucial for the localization of LRRK2 and is important for PD pathogenesis. In addition, phosphorylation of sites within the G-domain of the protein affect GTPase activity. Here we discuss the role of these (auto)-phosphorylation sites of LRRK2 and their regulation by phosphatases and upstream kinases.
引用
收藏
页码:643 / 647
页数:5
相关论文
共 50 条
  • [1] The Role of α-Synuclein and LRRK2 in Tau Phosphorylation
    Kawakami, Fumitaka
    Ichikawa, Takafumi
    PARKINSONS DISEASE, 2015, 2015
  • [2] LRRK2 Phosphorylation: Behind the Scenes
    De Wit, Tina
    Baekelandt, Veerle
    Lobbestael, Evy
    NEUROSCIENTIST, 2018, 24 (05): : 486 - 500
  • [3] LRRK2 Structure-Based Activation Mechanism and Pathogenesis
    Zhang, Xiaojuan
    Kortholt, Arjan
    BIOMOLECULES, 2023, 13 (04)
  • [4] Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biology
    Zhao, Jing
    Hermanson, Spencer B.
    Carlson, Coby B.
    Riddle, Steven M.
    Vogel, Kurt W.
    Bi, Kun
    Nichols, R. Jeremy
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1158 - 1162
  • [5] Roles of lysosomotropic agents on LRRK2 activation and Rab10 phosphorylation
    Kuwahara, Tomoki
    Funakawa, Kai
    Komori, Tadayuki
    Sakurai, Maria
    Yoshii, Gen
    Eguchi, Tomoya
    Fukuda, Mitsunori
    Iwatsubo, Takeshi
    NEUROBIOLOGY OF DISEASE, 2020, 145
  • [6] LRRK2 Phosphorylation, More Than an Epiphenomenon
    Marchand, Antoine
    Drouyer, Matthieu
    Sarchione, Alessia
    Chartier-Harlin, Marie-Christine
    Taymans, Jean-Marc
    FRONTIERS IN NEUROSCIENCE, 2020, 14
  • [7] Phosphorylation of LRRK2: from kinase to substrate
    Lobbestael, Evy
    Baekelandt, Veerle
    Taymans, Jean-Marc
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1102 - 1110
  • [8] Membrane association but not identity is required for LRRK2 activation and phosphorylation of Rab GTPases
    Gomez, Rachel C.
    Wawro, Paulina
    Lis, Pawel
    Alessi, Dario R.
    Pfeffer, Suzanne R.
    JOURNAL OF CELL BIOLOGY, 2019, 218 (12): : 4157 - 4170
  • [9] LRRK2: Cause, Risk, and Mechanism
    Paisan-Ruiz, Coro
    Lewis, Patrick A.
    Singleton, Andrew B.
    JOURNAL OF PARKINSONS DISEASE, 2013, 3 (02) : 85 - 103
  • [10] Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers
    Fraser, Kyle B.
    Moehle, Mark S.
    Alcalay, Roy N.
    West, Andrew B.
    NEUROLOGY, 2016, 86 (11) : 994 - 999